Adam S. Grossman - Feb 25, 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role: President and CEO, Director
Signature: /s/ Adam S. Grossman, by Brian Lenz as Attorney-in-fact
Stock symbol: ADMA
Transactions as of: Feb 25, 2023
Transactions value $: -$169,944
Form type: 4
Date filed: 3/8/2023, 08:30 PM
Previous filing: Jan 6, 2023
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADMA	Common Stock	Tax liability	-$13.7K	-4.02K	-0.2%	$3.42	2.03M	Feb 25, 2023	Direct
transaction	ADMA	Common Stock	Tax liability	-$49.3K	-14.4K	-0.71%	$3.42	2.02M	Feb 25, 2023	Direct
transaction	ADMA	Common Stock	Tax liability	-$26.6K	-7.51K	-0.37%	$3.55	2.01M	Feb 28, 2023	Direct
transaction	ADMA	Common Stock	Award	$0	+574K	+28.53%	$0.00	2.58M	Mar 6, 2023	Direct	F1
transaction	ADMA	Common Stock	Tax liability	-$80.3K	-23.6K	-0.91%	$3.40	2.56M	Mar 7, 2023	Direct	F2, F3, F4
holding	ADMA	Common Stock						1.14M	Feb 25, 2023	See Footnote	F4
holding	ADMA	Common Stock						581K	Feb 25, 2023	See Footnote	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADMA	Employee Stock Option (right to buy)	Award	$0	+1.15M		$0.00	1.15M	Mar 6, 2023	Common Stock	1.15M	$3.35	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes, as of the transaction date, (i) 573,695 RSUs granted on March 6, 2023 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 225,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 453,750 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;
F2	(continued from footnote 1) (iv) 104,341 unvested RSUs granted on February 25, 2021, of which 91,575 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 12,766 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;
F3	(continued from footnote 2) (v) 25,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 1,179,206 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
F4	These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
F5	These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.
F6	The options vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 6, 2027.